Angiotech Pharmaceuticals Inc (Pre-Merger) - ESG Rating & Company Profile powered by AI
This assessment of Angiotech Pharmaceuticals Inc (Pre-Merger) incorporates information from across the internet and also from public filings by Angiotech Pharmaceuticals Inc (Pre-Merger). If you work at Angiotech Pharmaceuticals Inc (Pre-Merger) and you would like to use your Sustainability rating, please get in touch. This SDG score for Angiotech Pharmaceuticals Inc (Pre-Merger) represents the company's transparency towards the UN SDGs.
Angiotech Pharmaceuticals Inc (Pre-Merger) in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
... | ... | ... | |
378 | Guangzhou Wondfo Biotech Co Ltd | 0.4 | Low |
379 | C R Bard Inc | 0.3 | Low |
380 | Angiotech Pharmaceuticals Inc (Pre-Merger) | 0.0 | Low |
380 | CU Medical Systems Inc | 0.0 | Low |
380 | Calypte Biomedical Corp | 0.0 | Low |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Angiotech Pharmaceuticals Inc (Pre-Merger) have an accelerator or VC vehicle to help deliver innovation?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose current and historical energy intensity?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) report the average age of the workforce?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) reference operational or capital allocation in relation to climate change?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose its ethnicity pay gap?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose cybersecurity risks?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) offer flexible work?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose the number of employees in R&D functions?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) conduct supply chain audits?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Angiotech Pharmaceuticals Inc (Pre-Merger) conduct 360 degree staff reviews?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose the individual responsible for D&I?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose current and / or historical scope 2 emissions?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose water use targets?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) have careers partnerships with academic institutions?
Did Angiotech Pharmaceuticals Inc (Pre-Merger) have a product recall in the last two years?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose incidents of discrimination?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) allow for Work Councils/Collective Agreements to be formed?
Has Angiotech Pharmaceuticals Inc (Pre-Merger) issued a profit warning in the past 24 months?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose parental leave metrics?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose climate scenario or pathway analysis?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose current and / or historical scope 1 emissions?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose the pay ratio of women to men?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) support suppliers with sustainability related research and development?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Angiotech Pharmaceuticals Inc (Pre-Merger) involved in embryonic stem cell research?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose GHG and Air Emissions intensity?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose its waste policy?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) report according to TCFD requirements?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose energy use targets?
Does Angiotech Pharmaceuticals Inc (Pre-Merger) disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Angiotech Pharmaceuticals Inc (Pre-Merger) have a policy relating to cyber security?
Have a different question?
Potential Risks for Angiotech Pharmaceuticals Inc (Pre-Merger)
These potential risks are based on the size, segment and geographies of the company.